T 1127/02 (Soluble and insoluble form of an antigen/CONNAUGHT) of 14.09.2004
- European Case Law Identifier
- ECLI:EP:BA:2004:T112702.20040914
- Date of decision
- 14 September 2004
- Case number
- T 1127/02
- Petition for review of
- -
- Application number
- 93307185.4
- IPC class
- A61K 39/00
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Composition containing both a soluble and an insoluble form of an immunogen
- Applicant name
- CONNAUGHT LABORATORIES INCORPORATED
- Opponent name
- GlaxoSmithKline Biologicals s.a.
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54 1973European Patent Convention Art 56 1973European Patent Convention Art 83 1973
- Keywords
- Main request - novelty (no)
Auxiliary request - sufficiency of disclosure, novelty, inventive step (yes) - Catchword
- -
ORDER
For these reasons it is decided:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the order to maintain the patent on the basis of the following documents:
claims: 1 to 4 filed during oral proceedings on 14 September 2004 as auxiliary request
description: pages 2 and 3 filed during the oral proceedings, pages 4 and 5 as granted
Figures: 1 to 9 as granted